Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer

Clinical trial NCT07070128 · RECRUITING

Trial details

NCT number: NCT07070128
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Neoplasms

Start date: 2025-08-20
Primary completion: 2026-08-11
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.